8-K
Current Report
PharmaCyte Biotech, Inc. Filed Acc 0001019687-14-003701
Material agreement · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.05 Amendment to or waiver of the code of ethics
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading nuvilex_8k-091914.htm…